These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 16415304

  • 21. Effects of long-term hormone treatment and of tibolone on monoamines and monoamine metabolites in the brains of ovariectomised, Cynomologous monkeys.
    Gibbs RB, Edwards D, Lazar N, Nelson D, Talameh J.
    J Neuroendocrinol; 2006 Sep; 18(9):643-54. PubMed ID: 16879163
    [Abstract] [Full Text] [Related]

  • 22. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G, Lambrinoudaki I, Panoulis C, Sioulas V, Rizos D, Caramalis G, Botsis D, Creatsas G.
    Maturitas; 2005 Apr 11; 50(4):321-30. PubMed ID: 15780533
    [Abstract] [Full Text] [Related]

  • 23. The Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study: design and baseline characteristics.
    Bots ML, Evans GW, Riley W, Meijer R, McBride KH, Paskett ED, Helmond FA, Grobbee DE, OPAL Investigators.
    Control Clin Trials; 2003 Dec 11; 24(6):752-75. PubMed ID: 14662281
    [Abstract] [Full Text] [Related]

  • 24. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N, Genazzani AD, Bernardi F, Casarosa E, Pieri M, Palumbo M, Picciarelli G, Gabbanini M, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2005 Mar 11; 20(3):144-9. PubMed ID: 16019353
    [Abstract] [Full Text] [Related]

  • 25. Assessment of DNA damage in postmenopausal women under hormone replacement therapy.
    Ozcagli E, Sardas S, Biri A.
    Maturitas; 2005 Jul 16; 51(3):280-5. PubMed ID: 15978971
    [Abstract] [Full Text] [Related]

  • 26. Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy.
    Kalyan S, Hitchcock CL, Sirrs S, Pudek M, Prior JC.
    Pharmacotherapy; 2010 May 16; 30(5):442-52. PubMed ID: 20411996
    [Abstract] [Full Text] [Related]

  • 27. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
    Osmanağaoğlu MA, Osmanağaoğlu S, Osmanağaoğlu T, Okumuş B, Bozkaya H.
    Fertil Steril; 2005 Aug 16; 84(2):384-93. PubMed ID: 16084879
    [Abstract] [Full Text] [Related]

  • 28. Comparison of tibolone and conjugated equine estrogens effects on carotid artery atherosclerosis of postmenopausal monkeys.
    Clarkson TB, Anthony MS, Mikkola TS, St Clair RW.
    Stroke; 2002 Nov 16; 33(11):2700-3. PubMed ID: 12411664
    [Abstract] [Full Text] [Related]

  • 29. Psychological effects of tibolone and sequential estrogen-progestogen therapy in perimenopausal women.
    Inan I, Kelekci S, Yilmaz B.
    Gynecol Endocrinol; 2005 Feb 16; 20(2):64-7. PubMed ID: 15823823
    [Abstract] [Full Text] [Related]

  • 30. Effects of tibolone and conventional HRT on the expression of estrogen and progesterone receptors in the breast.
    Ma L, Hofling M, Masironi B, von Schoultz B, Cline JM, Sahlin L.
    Maturitas; 2008 Dec 20; 61(4):345-9. PubMed ID: 18980817
    [Abstract] [Full Text] [Related]

  • 31. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS, Women's Health Initiative Mammogram Density Study Investigators.
    J Natl Cancer Inst; 2005 Sep 21; 97(18):1366-76. PubMed ID: 16174858
    [Abstract] [Full Text] [Related]

  • 32. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA, Liu JH, Speroff L, Shumel BS, Symons JP.
    Am J Obstet Gynecol; 2003 Jan 21; 188(1):92-9. PubMed ID: 12548201
    [Abstract] [Full Text] [Related]

  • 33. Endometrial effects of tibolone.
    Archer DF, Hendrix S, Gallagher JC, Rymer J, Skouby S, Ferenczy A, den Hollander W, Stathopoulos V, Helmond FA.
    J Clin Endocrinol Metab; 2007 Mar 21; 92(3):911-8. PubMed ID: 17192288
    [Abstract] [Full Text] [Related]

  • 34. [Comparative study on two different dosages of conjugated equine estrogen continuously combined with medroxyprogesterone in prevention of postmenopausal osteoporosis].
    Wu Y, Liu J, Xing S, Xu R, Zhang Z, Wang Y.
    Zhonghua Fu Chan Ke Za Zhi; 2002 May 21; 37(5):267-70. PubMed ID: 12133397
    [Abstract] [Full Text] [Related]

  • 35. Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.
    Christodoulakos GE, Lambrinoudaki IV, Panoulis CP, Papadias CA, Kouskouni EE, Creatsas GC.
    Gynecol Endocrinol; 2004 May 21; 18(5):244-57. PubMed ID: 15346660
    [Abstract] [Full Text] [Related]

  • 36. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
    Modena MG, Sismondi P, Mueck AO, Kuttenn F, Lignières Bd, Verhaeghe J, Foidart JM, Caufriez A, Genazzani AR, TREAT.
    Maturitas; 2005 Sep 16; 52(1):1-10. PubMed ID: 15963666
    [Abstract] [Full Text] [Related]

  • 37. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA.
    Climacteric; 2007 Oct 16; 10 Suppl 2():27-31. PubMed ID: 17882669
    [Abstract] [Full Text] [Related]

  • 38. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
    Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH, Women's Health Initiative Memory Study.
    JAMA; 2004 Jun 23; 291(24):2947-58. PubMed ID: 15213206
    [Abstract] [Full Text] [Related]

  • 39. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
    Christodoulakos GE, Botsis DS, Lambrinoudaki IV, Papagianni VD, Panoulis CP, Creatsa MG, Alexandrou AP, Augoulea AD, Dendrinos SG, Creatsas GC.
    Maturitas; 2006 Mar 20; 53(4):413-23. PubMed ID: 16140483
    [Abstract] [Full Text] [Related]

  • 40. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study.
    Chandeying V, Sangthawan M.
    J Med Assoc Thai; 2007 Sep 20; 90(9):1720-6. PubMed ID: 17957910
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.